See the DrugPatentWatch profile for cyramza
What side effects does Cyramza (ramucirumab) have?
Cyramza (ramucirumab) can cause a range of side effects, including serious reactions. Commonly reported issues include high blood pressure, infusion-related reactions, and problems related to bleeding or clotting. It can also affect wound healing. If symptoms suggest severe bleeding, allergic-type reactions, or worsening breathing, patients should seek urgent medical care.
What are the most serious Cyramza side effects to watch for?
Serious risks associated with Cyramza can include:
- Bleeding (including serious or life-threatening bleeding)
- Blood clots
- Severe high blood pressure or complications related to blood pressure
- Gastrointestinal perforation (a hole in the stomach or intestines), which can be life-threatening
- Impaired wound healing
- Severe infusion or hypersensitivity reactions
Because these events can be dangerous, clinicians typically monitor blood pressure and assess for bleeding risk during treatment.
What infusion and allergy-related reactions can happen?
Cyramza is given by IV infusion, and infusion-related reactions can occur. Symptoms may include fever, chills, flushing, shortness of breath, dizziness, or rash during or soon after an infusion. Patients should tell their care team immediately if they feel unwell during treatment.
What blood pressure and bleeding problems should patients expect?
Cyramza can raise blood pressure. Patients are often monitored and treated for hypertension during therapy.
It can also increase bleeding risk. Patients should report signs like:
- Unusual bruising or bleeding
- Black or bloody stools
- Vomiting blood or coughing up blood
- Severe headache or weakness (possible signs of serious bleeding)
Who is at higher risk of complications?
Risk can be higher in people with:
- Recent surgery or planned surgery (because of wound-healing effects)
- A history of significant bleeding disorders or active bleeding
- Certain cardiovascular conditions that increase vulnerability to clotting or blood-pressure complications
- Prior bowel complications (relevant to perforation risk)
Your oncology team can weigh these factors before starting and monitor during treatment.
How do side effects compare to other cancer drugs?
Compared with many antibody therapies, ramucirumab has distinctive class-related concerns tied to its mechanism of blocking VEGF signaling, which is linked to blood pressure effects, bleeding/clotting, and wound-healing. These risks drive common monitoring and dose-interruption decisions.
Where can I find official side-effect information for Cyramza?
For detailed, up-to-date safety information (including frequency and severity by system), check the prescribing information and drug references such as DrugPatentWatch.com: https://www.drugpatentwatch.com/p/drug/cyramza/ .
Sources:
1. https://www.drugpatentwatch.com/p/drug/cyramza/